Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

Berkeley Lights looks to CAR-T manufacture after securing $95m investment

This week Berkeley announced it had tied up a financing round and signed a cell line development deal with Selexis.

Samsung Bioepis joins Humira biosimilar market in Europe

Samsung Bioepis’ version of AbbVie blockbuster Humira is the third biosimilar to launch in Europe this week.

National Research Council of Canada signs cannabinoid biosynthesis agreement

InMed Pharmaceuticals signed an agreement with the National Research Council of Canada for cannabinoid biofermentation development.

CBMG inks Kymriah deal: ‘China could take the lead in cell therapies’

CBMG announced a manufacturing collaboration agreement with Novartis at the end of last month to produce CAR-T treatment Kymriah for the Chinese market and the company has further ambitions in the pipeline.

MSD adds vaccine and biologics facility next to Keytruda site, creates 170 jobs

MSD will build a second manufacturing plant in County Carlow, Ireland, in response to growing demand.

Global Industry News

Hot Topics

Spotlight

The rise of bio-education: Pall Biotech inks latest training centre deal

Orchard Therapeutics plans to go public to raise $172m

First wave of Humira biosimilars enters EU market

US FDA approves the manufacturing of rare lung disease treatment

Lonza expands manufacturing sites for larger ADC payloads

Products

Webinars

On-demand webinars

Marken: Global Life Science Supply Chain Solutions Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Bio-Rad Laboratories

Marken: Global Life Science Supply Chain Solutions

Merck KGaA, Darmstadt, Germany

Samsung BioLogics